Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies
In: Clinical lymphoma, myeloma & leukemia, Jg. 23 (2023), Heft 9, S. 674-686
serialPeriodical
Zugriff:
Titel: |
Phase 1/2 Study of the Pan-PIM Kinase Inhibitor INCB053914 Alone or in Combination With Standard-of-Care Agents in Patients With Advanced Hematologic Malignancies
|
---|---|
Autor/in / Beteiligte Person: | Patel, Manish R. ; Donnellan, William ; Byrne, Michael ; Asch, Adam S. ; Zeidan, Amer M. ; Baer, Maria R. ; Fathi, Amir T. ; Kuykendall, Andrew T. ; Zheng, Fred ; Walker, Chris ; Cheng, Lulu ; Marando, Cindy ; Savona, Michael R. |
Link: | |
Zeitschrift: | Clinical lymphoma, myeloma & leukemia, Jg. 23 (2023), Heft 9, S. 674-686 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 2152-2650 (print) |
Sonstiges: |
|